Efficacy and Pharmacokinetics of Gallopamil in Patients with Coronary Artery Disease

Author： Ferrara N. Longobardi G. Guerra N. Nicolino A. Acanfora D. Furgi G. Odierna L. Rosiello R. Rengo F.

ISSN： 1043-6618

Source： Pharmacological Research, Vol.34, Iss.1, 1996-07, pp. : 37-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Stable Coronary Artery Disease: Results from the ONSET-OFFSET and RESPOND Studies

By Husted Steen E.

Clinical Pharmacokinetics, Vol. 51, Iss. 6, 2012-06 ,pp. : 397-409

Adis International

Access to resources Recommend Favorite

C.E.R.A.: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney disease

By Locatelli Francesco Reigner Bruno

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1649-1661

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease

By Pothula A. Serebruany V.L. Gurbel P. McKenzie M.E. Atar D.

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Perindopril: A Review of its Use in Patients With or at Risk of Developing Coronary Artery Disease

By Curran Monique P. McCormack Paul L. Simpson Dene

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 235-255

Adis International

Access to resources Recommend Favorite

Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease

By Boudoulas H Georgiadou P Iliodromitis EK Varounis C Mavroidis M Kolokathis F Andreadou I Psarras S Capetanaki Y Kremastinos D Th

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 917-920

Informa Healthcare

Access to resources Recommend Favorite